Mead Johnson Nutrition CO (MJN) Receiving Somewhat Favorable News Coverage, Analysis Finds
News coverage about Mead Johnson Nutrition CO (NYSE:MJN) has trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Mead Johnson Nutrition CO earned a news sentiment score of 0.11 on Accern’s scale. Accern also gave media headlines about the company an impact score of 46.811310424842 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
These are some of the news stories that may have effected Accern Sentiment’s scoring:
- Beaten at Home, Chinese Milk Formula Makers Forge Ties Abroad (bloomberg.com)
- Global Infant Nutrition Market Segment by Types (Baby Food and Infant Formula) (sbwire.com)
- Enteral Feeding Formulas Market Size for Long-Term Care Facilities by Type 2017 (medgadget.com)
- Mead Johnson Nutrition CO Given Day To Day Media Opinion Points of 0.08 – Insider Tradings (insidertradings.org)
- Medical Nutrition Market is Expected to Reach US$ 6,046.3 Mn by 2025 – Persistence Market Research (prnewswire.co.uk)
Several research firms recently commented on MJN. BMO Capital Markets reaffirmed a “hold” rating and set a $90.00 target price on shares of Mead Johnson Nutrition CO in a report on Thursday, June 15th. BidaskClub raised shares of Mead Johnson Nutrition CO from a “sell” rating to a “hold” rating in a report on Wednesday, June 14th. Finally, Canaccord Genuity reaffirmed a “speculative buy” rating on shares of Mead Johnson Nutrition CO in a report on Wednesday, July 5th. Two analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company’s stock. Mead Johnson Nutrition CO presently has a consensus rating of “Hold” and an average target price of $83.18.
Shares of Mead Johnson Nutrition CO (NYSE MJN) traded down 0.01% during midday trading on Friday, reaching $89.98. 11,923,467 shares of the company’s stock traded hands. Mead Johnson Nutrition CO has a one year low of $69.25 and a one year high of $94.40. The company has a market capitalization of $16.52 billion, a price-to-earnings ratio of 25.42 and a beta of 1.57. The company has a 50-day moving average of $89.62 and a 200-day moving average of $84.34.
Mead Johnson Nutrition CO Company Profile
Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, Latin America and North America/Europe. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.
Receive News & Ratings for Mead Johnson Nutrition CO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition CO and related companies with Analyst Ratings Network's FREE daily email newsletter.